title: Severe generalized pustular psoriasis accompanied by bullae formation with increased serum vascular endothelial growth factor level.
authors.forename: Mizuho
authors.initials: M
authors.lastname: Yamamoto
authors.forename: Yayoi
authors.initials: Y
authors.lastname: Tada
authors.forename: Akihiko
authors.initials: A
authors.lastname: Asahina
authors.forename: Hidehisa
authors.initials: H
authors.lastname: Saeki
authors.forename: Yoshihide
authors.initials: Y
authors.lastname: Asano
authors.forename: Takayuki
authors.initials: T
authors.lastname: Kimura
authors.forename: Makoto
authors.initials: M
authors.lastname: Sugaya
authors.forename: Kanako
authors.initials: K
authors.lastname: Kikuchi
authors.forename: Kunihiko
authors.initials: K
authors.lastname: Tamaki
authors.forename: Shinichi
authors.initials: S
authors.lastname: Sato
mesh_terms: D001768:Blister / Q000097:blood* / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D002762:Cholecalciferol / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005050:Etretinate / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D011565:Psoriasis / Q000097:blood* / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D016896:Treatment Outcome; D014467:Ultraviolet Therapy; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*
chemical_list: D003879:Dermatologic Agents; D042461:Vascular Endothelial Growth Factor A; D002762:Cholecalciferol; D005050:Etretinate; D016572:Cyclosporine